- Farmakologi Dan Terapi Edisi 6 Pdf Online
- Ebook Farmakologi Dan Terapi Ui Edisi 6 Pdf
- Farmakologi Dan Terapi Edisi 6 Pdf File
8b9facfde6 TatalaksanaOAmeliputiterapinonfarmakologi,terapifarmakologi,dan.FullText:##PDF##.released31.
Kortikosteroid Sistemik: Aspek Farmakologi Dan Penggunaan Klinis Di Bidang Dermatologi
- Download full-text PDF Read full-text. Farmakologi dan terapi. Jakarta: Badan Penerbit. Tercapainya outcome terapi, dan tidak terdapat perbedaan efek aktual namun tidak berbeda.
- Visi dan Misi Departemen Farmakologi & Terapeutik FKUI Visi: Menjadi salah satu sentra pendidikan, penelitian, dan pelayanan / pengabdian masyarakat dalam bidang Farmakologi yang unggul di Indonesia tahun 2010 dan di Asia Pasifik tahun 2020. Misi: Menyelenggarakan pendidikan dan pelatihan dalam bidang Farmakologi dan Terapi yang bermutu.
- Farmakologi dan Terapi, Edisi 5, Jakarta, Fakultas Kedokteran Universitas Indonesia. Honorato SB, Farfan S, Viana A, Filho JM, Camarao GC, Fechin FV, Moraes MEA, Moraes MO, Ferro M, Dabbene V, Cuffini SL, and Ayala AP, 2012. Polymorphism evaluation in generic tablets containing mebendazole.
Sari
Kata kunci: kortikosteroid sistemik, penggunaan klinis, efek samping, farmakologi
Referensi
Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, dkk. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9:1-25. doi:10.1186/1710-1492-9-30.
Djuanda A. Pengobatan dengan kortikosteroid sistemik dalam bidang dermatovenereologi. Dalam: Djuanda A, Hamzah M, Aisah S, penyunting. Ilmu penyakit kulit dan kelamin. Edisi ke-6. Jakarta: Badan Penerbit FKUI; 2011.h. 339-41.
Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. Q J Med. 2000;93:105-11.
Gupta P, Bhatia V. Corticosteroid physiology and principles of therapy. Indian J Pediatr.2008;75:1039-44.
Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, dkk. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. doi:10.1136/bmj.j1415.
Min KH, Rhee C, Jung JY, Suh M. Characteristics of adverse effects when using high dose short term steroid regimen. Korean J Audiol. 2012;16:65-70. doi:10.7874/kja.2012.16.2.65.
Farmakologi Dan Terapi Edisi 6 Pdf Online
Ericson-Neilsen W, Kaye AD. Steroids: pharmacology, complications, and practice delivery issues. The Ochsner J. 2014;14:203-7.
Listiyawati IT, Sawitri, Agusni I, Prakoeswa CR. Terapi kortikosteroid oral pada pasien baru kusta dengan reaksi tipe 2. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2015;27:48-54.
Schimmer BP, Parker KL. Adrenocorticotropic hormone, adrenocortical steroids and their synthetic analogs, inhibitors of the synthesis and actions of adrenocortical hormones. Dalam: Brunton LL, Lazo JS, Parker KL. Goodman and Gilman’s The pharmacological basis of therapeutics. Edisi ke-11. New York: McGraw-Hill, Medical Publishing Division; 2006.h.1587-612.
Chrousos GP. Adrenocorticosteroids and adrenocortical antagonists. Dalam: Katzung BG, Masters SB, Trevor AJ. Basic and clinical pharmacology. Edisi ke-12. New York: McGraw-Hill Lange; 2012.h. 697-713.
Suherman SK, Ascobat P. Adrenokortikotropin, adrenokortikosteroid, analog sintetik dan antagonisnya. Dalam: Gunawan SG, Setiabudy R, Nafrialdi, Instiaty, penyunting. Farmakologi dan terapi. Edisi ke-6. Jakarta: Badan Penerbit FKUI; 2016. h 507-27.
Becker DE. Basic and clinical pharmacology of glucocorticosteroids. Anesth Prog. 2013;60:25-32.
Flammer JR, Rogatsky I. Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms. Mol Endocrinol. 2011;25:1075-86. doi:10.1210/me.2011-0068.
Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: a comprehensive review. J Am Acad Dermatol. 2017;76:1-9. doi:10.1016/j.jaad.2016.01.062.
Ebook Farmakologi Dan Terapi Ui Edisi 6 Pdf
Deshmukh CT. Minimizing side effects of systemic corticosteroids in children. Indian J Dermatol Venereol Leprol. 2007;73:218-21.
Eckstein N, Haas B, Hass MD, Pfeifer V. Systemic therapy of cushing’s syndrome. Orphanet J Rare Diseases. 2014;9:1-16. doi:10.1186/s13023-014-0122-8.
Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Safety. 2007;30:861-81.
Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick’s dermatology in general medicine. Edisi ke-8. New York: The McGraw-Hill Companies; 2012.h.165-2720.
Hopkins RL, Leinung MC. Exogenous cushing’s syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin N Am. 2005;34:371-84. doi:10.1016/j.ecl.2005.01.013.
Alves C, Robazzi TC, Mendonca M. Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. J Pediatr. 2008;84(3):192-202. doi:10.2223/JPED.1773.
Vatti RR, Ali F, Teuber S, Chang C, Gershwin ME. Hypersensitivity reactions to corticosteroids. Clinic Rev Allerg Immunol. 2014;47:26-37. doi:10.1007/s12016-013-8365-z.
Nocentini G, Ronchetti S, Bruscoli S, Riccardi C. The clinical pharmacology of past, present, and future glucocorticoids. Spring Int Publis. 2015:43-58. doi:10.1007/978-3-319-16056-6_5.
Gross KL, Lu NZ, Cidlowski JA. Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol. 2009;300:7-16. doi:10.1016/j.mce.2008.10.001.
Farmakologi Dan Terapi Edisi 6 Pdf File
DOI: https://doi.org/10.33820/mdvi.v45i3.33
Refbacks
- Saat ini tidak ada refbacks.
INDEXED IN